{"product_id":"evidence-based-hematology-isbn-9781405157476","title":"Evidence-Based Hematology","description":"This unique new book uses a series of focussed questions, comprehensive literature evaluations and structured grades of recommendation to provide evidence for the treatment of hematological disorders, both malignant and benign. With contributions from leading international experts who have a real understanding of evidence-based medicine the book provides comprehensive reviews accompanied by clinical commentaries and recommendations on the best treatment regimes to adopt for individual patients.\u003cbr\u003e \u003cbr\u003e The book is split into two sections: the first examines the methodology underlying evidence based practice, and the second concentrates on the clinical practice of hematology, providing current “best evidence” to guide practice in a series of well-defined clinical situations.\u003cbr\u003e \u003cbr\u003e This clinical reference is an invaluable source of evidence-based information distilled into guidance for clinical practice which will be welcomed by practitioners, trainees and associated health professionals. \u003cp\u003eList of Contributors vii\u003c\/p\u003e \u003cp\u003ePreface xi\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 1 A Guide to the Evidence\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eEditor: Holger J. Sch\u003c\/i\u003e\u003ci\u003eünemann\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e1 Rating the Quality of Evidence and Making Recommendations: A Guide to the Spectrum of Clinical Research 3\u003cbr\u003e\u003ci\u003eHolger J. Sch\u003c\/i\u003e\u003ci\u003eünemann, Martin Stanulla, Jan L. Brozek, Gordon G. Guyatt\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e2 An Overview of Systematic Reviews 10\u003cbr\u003e\u003ci\u003eMartin Prins, Arina ten Cate-Hoek, Pieter Leffers\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e3 Interpreting Results in Clinical Research: Overview of measures of effect, measures of precision, and measures of diagnostic accuracy for clinicians and researchers 15\u003cbr\u003e\u003ci\u003eMarcello Di Nisio, Harry R. B\u003c\/i\u003e\u003ci\u003eüller, Patrick M. M. Bossuyt\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e4 Finding the Evidence in Hematology 23\u003cbr\u003e\u003ci\u003eK. Ann McKibbon, Cynthia J. Walker-Dilks, R. Brian Haynes\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e5 Applying EBM in Clinical Practice 32\u003cbr\u003e\u003ci\u003eAlessandro Squizzato, Walter Ageno, Davide Imberti\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e6 Using Evidence to Guide the Diagnosis of Disease 37\u003cbr\u003e\u003ci\u003eLucas M. Bachmann, Holger J. Sch\u003c\/i\u003e\u003ci\u003eünemann\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 2 Hemostasis and Thrombosis\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eEditor: Jeff Ginsberg\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e7 Diagnosis of Deep Vein Thrombosis 49\u003cbr\u003e\u003ci\u003eLori-Ann Linkins\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e8 The Diagnosis of Acute Pulmonary Embolism 56\u003cbr\u003e\u003ci\u003eVictor F. Tapson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9 Initial Therapy of Deep Vein Thrombosis and Pulmonary Embolism 65\u003cbr\u003e\u003ci\u003eSam Schulman\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e10 Long-Term Anticoagulation in Venous Thromboembolism 73\u003cbr\u003e\u003ci\u003eClive Kearon\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e11 Thrombolytic Therapy for Deep Vein Thrombosis and Pulmonary Embolism 88\u003cbr\u003e\u003ci\u003eSimon J. McRae, John W. Eikelboom\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e12 Inferior Vena Cava Interruption 99\u003cbr\u003e\u003ci\u003eMichael B. Streiff, Christine L. Hann\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e13 Management of Venous Thromboembolism in Pregnancy 110\u003cbr\u003e\u003ci\u003eWee-Shian Chan\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e14 Pediatric Thrombosis 120\u003cbr\u003e\u003ci\u003eAnthony K. C. Chan, Paul Monagle\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e15 Bridging Anticoagulation in Patients Who Require Temporary Interruption of Warfarin for Surgery 124\u003cbr\u003e\u003ci\u003eJames D. Douketis, Scott Kaatz\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e16 Evidence-based Approach to the Diagnosis and Management of Thrombotic Thrombocytopenic Purpura 131\u003cbr\u003e\u003ci\u003eBrian Boulmay, Craig S. Kitchens\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e17 Diagnosis and Management of Disseminated Intravascular Coagulation 138\u003cbr\u003e\u003ci\u003eJulia A. M. Anderson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e18 Diagnosis and Management of Hereditary Bleeding Disorders: Including Congenital\/Acquired Platelet Function Disorders 145\u003cbr\u003e\u003ci\u003eNigel S. Key, Alice D. Ma\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e19 Diagnosis and Management of Acquired Bleeding Disorders: Vitamin K Antagonists 152\u003cbr\u003e\u003ci\u003eMiguel A. Escobar\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e20 Diagnosis and Management of Heparin-Induced Thrombocytopenia 158\u003cbr\u003e\u003ci\u003eTheodore E. Warkentin, Andreas Greinacher\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e21 Management of Antiphospholipid Antibody Syndrome 168\u003cbr\u003e\u003ci\u003eWendy Lim, Mark A. Crowther\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 3 Benign Hematologic Disorders\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eEditor: Richard Lottenberg\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e22 Clinical Questions in Iron Overload 179\u003cbr\u003e\u003ci\u003eAntonello Pietrangelo, Nicola Magrini\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e23 Aplastic Anemia, Paroxysmal Nocturnal Hemoglobinuria, and Pure Red Cell Aplasia 189\u003cbr\u003e\u003ci\u003eShivani Srivastava, Richard W. Childs\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e24 Acquired Anemias: Iron Deficiency, Cobalamin Deficiency, and Autoimmune Hemolytic Anemia 197\u003cbr\u003e\u003ci\u003eMarc S. Zumberg, Marc J. Kahn\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e25 Immune Thrombocytopenic Purpura 206\u003cbr\u003e\u003ci\u003eJames N. George, Sara K. Vesely, George R. Buchanan\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e26 Neutropenia 215\u003cbr\u003e\u003ci\u003eDavid C. Dale\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e27 Hypereosinophilia: Primary and Secondary 221\u003cbr\u003e\u003ci\u003eFlorence Roufosse, Michel Goldman, Elie Cogan\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e28 Porphyrias 229\u003cbr\u003e\u003ci\u003eGagan Sood, Karl E. Anderson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e29 Membrane and Enzyme Abnormalities of the Erythrocyte 238\u003cbr\u003e\u003ci\u003ePatrick G. Gallagher, Ernest Beutler\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e30 Sickle Cell Disease 244\u003cbr\u003e\u003ci\u003eRichard Lottenberg, Sally C. Davies\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e31 Evidence-based Treatment of Thalassemia Major 251\u003cbr\u003e\u003ci\u003eIssac Odame, Deborah Rund\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePart 4 Malignant Hematologic Disorders\u003cbr\u003e\u003c\/b\u003e\u003ci\u003eEditor: Ralph M. Meyer\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e32 Acute Lymphoblastic Leukemia in Adults 263\u003cbr\u003e\u003ci\u003eStephen Couban, Andrea Kew\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e33 Acute Myeloid Leukemia in Adults: Remission Induction Therapy 268\u003cbr\u003e\u003ci\u003eCara A. Rosenbaum, Richard A. Larson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e34 Acute Myeloid Leukemia in Adults: Postremission Therapy 278\u003cbr\u003e\u003ci\u003eCara A. Rosenbaum, Richard A. Larson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e35 Current Areas of Controversy in the Treatment of Patients With Newly Diagnosed Acute Promyelocytic Leukemia 287\u003cbr\u003e\u003ci\u003eMartin S. Tallman, Syed A. Abutalib\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e36 Chronic Lymphocytic Leukemia 294\u003cbr\u003e\u003ci\u003eBruce D. Cheson\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e37 Chronic Myeloid Leukemia 300\u003cbr\u003e\u003ci\u003eIrwin Walker\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e38 Selected Management of Patients with Myelodysplastic Syndromes 305\u003cbr\u003e\u003ci\u003eJohn M. Storring, Karen W. L. Yee\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e39 Evidence-based Treatment of Burkitt Lymphoma in Adults 311\u003cbr\u003e\u003ci\u003eJohn Gerecitano, David J. Straus\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e40 Primary Central Nervous System Lymphoma 317\u003cbr\u003e\u003ci\u003eTamara Shenkier\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e41 Diffuse Large B-cell Lymphoma 327\u003cbr\u003e\u003ci\u003eMichael Crump\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e42 Follicular Lymphoma 334\u003cbr\u003e\u003ci\u003eKevin Imrie, Matthew Cheung\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e43 Lymphoblastic Lymphoma 342\u003cbr\u003e\u003ci\u003eTyler Y. Kang, John W. Sweetenham\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e44 Mantle Cell Lymphoma 347\u003cbr\u003e\u003ci\u003eC. Tom Kouroukis\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e45 Management of Patients with Peripheral T-cell Lymphoma 352\u003cbr\u003e\u003ci\u003eKerry J. Savage\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e46 Selected Management Issues of Patients with Hodgkin Lymphoma 365\u003cbr\u003e\u003ci\u003eRalph M. Meyer\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e47 Lymphocyte Predominant Hodgkin Lymphoma 372\u003cbr\u003e\u003ci\u003eBrandon McMahon, Jonathan W. Friedberg\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e48 Management of Patients with Essential Thrombocythemia 378\u003cbr\u003e\u003ci\u003eGuido Finazzi, Giovanni Barosi, Tiziano Barbui\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e49 Management of Patients with Polycythemia Vera 385\u003cbr\u003e\u003ci\u003eGuido Finazzi, Roberto Marchioli, Tiziano Barbui\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e50 Evidence-based Review of Therapies in Multiple Myeloma 390\u003cbr\u003e\u003ci\u003eMichael Sebag, A. Keith Stewart\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e51 Management of Waldenstrom’s Macroglobulinemia 396\u003cbr\u003e\u003ci\u003eChristine I. Chen\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e52 The Role of Hematopoietic Growth Factors in Managing Patients with Hematologic Malignancies 402\u003cbr\u003e\u003ci\u003eHeloisa P. Soares, Ambuj Kumar, Charles Bennett, Benjamin Djulbegovic\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIndex 413\u003c\/p\u003e \"This book is an excellent collection of current best practices in hematology. It should appeal to all who have to deal with everyday challenges in blood diseases.\" (Journal of Tropical Pediatrics, June 2009)  \u003cp\u003e\u003cb\u003eMark A. Crowther,\u003c\/b\u003e MD, MSc, FRCPC McMaster University, Hamilton, Ontario, Canada \u003c\/p\u003e\u003cp\u003e\u003cb\u003eJeff Ginsberg,\u003c\/b\u003e MD, FRCPC, McMaster University, Hamilton, Ontario, Canada \u003c\/p\u003e\u003cp\u003e\u003cb\u003eHolger J. Schünemann,\u003c\/b\u003e MD, PhD, MSc, FACP, FCCP, Italian National Cancer Institute, Rome, Italy \u003c\/p\u003e\u003cp\u003e\u003cb\u003eRalph M. Meyer,\u003c\/b\u003e MD, FRCPC Queen's University, Kingston, Ontario, Canada \u003c\/p\u003e\u003cp\u003e\u003cb\u003eRichard Lottenberg,\u003c\/b\u003e MD, FACP, University of Florida, Gainesville, FL, USA   \u003c\/p\u003e\u003cp\u003e\u003cb\u003eEVIDENCE-BASED HEMATOLOGY\u003c\/b\u003e \u003c\/p\u003e\u003cp\u003eThis unique new book uses a series of focussed questions, comprehensive literature evaluations and structured grades of recommendation to provide evidence for the treatment of hematological disorders, both malignant and benign. With contributions from leading international experts who have a real understanding of evidence-based medicine the book provides comprehensive reviews accompanied by clinical commentaries and recommendations on the best treatment regimes to adopt for individual patients. \u003c\/p\u003e\u003cp\u003eThe book is split into two sections: the first examines the methodology underlying evidence-based practice, and the second concentrates on the clinical practice of hematology, providing current best evidence to guide practice in a series of well-defined clinical situations. \u003c\/p\u003e\u003cp\u003eThis clinical reference is an invaluable source of evidence-based information distilled into guidance for clinical practice which will be welcomed by practitioners, trainees and associated health professionals.\u003c\/p\u003e","brand":"BMJ Books","offers":[{"title":"Default Title","offer_id":47989175582949,"sku":"NP9781405157476","price":364.95,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9781405157476.jpg?v=1761783097","url":"https:\/\/k12savings.com\/products\/evidence-based-hematology-isbn-9781405157476","provider":"K12savings","version":"1.0","type":"link"}